IMBERTI, Davide
 Distribuzione geografica
Continente #
AS - Asia 914
NA - Nord America 624
SA - Sud America 181
EU - Europa 175
AF - Africa 44
OC - Oceania 1
Totale 1.939
Nazione #
US - Stati Uniti d'America 591
SG - Singapore 413
VN - Vietnam 235
BR - Brasile 108
FR - Francia 105
CN - Cina 70
IN - India 38
AR - Argentina 25
BD - Bangladesh 21
IT - Italia 21
IQ - Iraq 20
HK - Hong Kong 19
ZA - Sudafrica 14
MX - Messico 13
PH - Filippine 13
GB - Regno Unito 12
ID - Indonesia 12
EC - Ecuador 11
TR - Turchia 11
VE - Venezuela 11
CO - Colombia 10
PK - Pakistan 10
MA - Marocco 9
DE - Germania 8
RU - Federazione Russa 8
SA - Arabia Saudita 8
CL - Cile 7
EG - Egitto 5
JM - Giamaica 5
JP - Giappone 5
KE - Kenya 5
MY - Malesia 5
PL - Polonia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CA - Canada 4
DO - Repubblica Dominicana 4
ES - Italia 4
TH - Thailandia 4
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
NI - Nicaragua 3
PS - Palestinian Territory 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
IL - Israele 2
LT - Lituania 2
NL - Olanda 2
NP - Nepal 2
SE - Svezia 2
TW - Taiwan 2
UA - Ucraina 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
CR - Costa Rica 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MV - Maldive 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 1.939
Città #
San Jose 344
Singapore 154
Lauterbourg 101
Ho Chi Minh City 76
Ashburn 62
Hanoi 61
Buffalo 33
Los Angeles 33
Boardman 20
Hong Kong 12
Baghdad 11
Orem 8
Caracas 6
Rome 6
São Paulo 6
Da Nang 5
Haiphong 5
Karbala 5
Baku 4
Biên Hòa 4
Cairo 4
Casablanca 4
Denver 4
Durban 4
Guayaquil 4
Johannesburg 4
Lahore 4
Manchester 4
Manila 4
Medellín 4
New York 4
Nuremberg 4
Quito 4
Tashkent 4
Tây Ninh 4
Warsaw 4
Brasília 3
Dallas 3
Hyderabad 3
Hải Dương 3
Jaipur 3
Kenitra 3
Kingston 3
Managua 3
Mexicali 3
Mexico City 3
Milan 3
Nairobi 3
Passo Fundo 3
Riyadh 3
Santa Clara 3
Santiago 3
Thái Bình 3
Tokyo 3
Vĩnh Long 3
Adana 2
Addis Ababa 2
Ambato 2
Amman 2
Ankara 2
Asunción 2
Atlanta 2
Belo Horizonte 2
Buenos Aires 2
Bến Tre 2
Can Tho 2
Chengdu 2
Chennai 2
Curitiba 2
Dammam 2
Delhi 2
Dhaka 2
Fortaleza 2
Goianésia 2
Guangzhou 2
Isidro Casanova 2
Istanbul 2
Jakarta 2
Jeddah 2
Jinan 2
Karachi 2
Kolkata 2
La Tablada 2
London 2
Ludhiana 2
Marília 2
Montevideo 2
Mumbai 2
New Delhi 2
Ninh Bình 2
Osasco 2
Poplar 2
Querétaro 2
Quận Hai 2
Redondo Beach 2
Rio de Janeiro 2
San Miguel de Tucumán 2
Santarém 2
Santo André 2
Santo Domingo 2
Totale 1.167
Nome #
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery 42
D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism 36
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 34
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry 33
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 31
Clinical experience with retrievable vena cava filters: results of a prospective observational multicenter study 29
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry 29
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain 28
A survey of thromboprophylaxis management in patients with major trauma 26
Retrievable vena cava filters: a review 26
A survey of thrombosis prophylaxis use in patients with lower limb fractures 26
Clinical management of rivaroxaban-treated patients 26
"Timing" of arrival and in-hospital mortality in a cohort of patients under anticoagulant therapy presenting to the emergency departments with cerebral hemorrhage: A multicenter chronobiological study in Italy 26
An association between residual vein thrombosis and subclinical atherosclerosis: Cross-sectional study 25
Low-Molecular-Weight Heparins: Before or After Surgery? New Concepts and Evidence Congress Report from the SIGMA TAU/ROVI Satellite Symposium (Rome, Italy, 13 November 2006) 25
Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 25
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry 25
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms 25
A survey on the views and attitudes of Italian physicians regarding the prophylaxis and treatment of venous thromboembolism 24
Inferior vena cava filters: use or abuse? 24
Prophylaxis of Venous Thromboembolism with Low Molecular Weight Heparin in Bariatric Surgery: a Prospective, Randomised Pilot Study Evaluating Two Doses of Parnaparin (BAFLUX Study) 24
Retrievable vena cava filters: clinical experience 23
Prothrombin Complex Concentrates for Urgent Anticoagulation Reversal in Patients with Intracranial Haemorrhage 23
Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry 23
A commentary: To screen for calf DVT or not to screen? The highly variable practice among Italian centers highlights this important and still unresolved clinical option. Results from the Italian MASTER registry 23
Serial 2-point ultrasonography plus D-Dimer vs whole-leg color-coded doppler ultrasonography for diagnosing suspected symptomatic deep vein thrombosis - A randomized controlled trial 22
Venous thromboembolism after major orthopaedic surgery: a population-based cohort study 22
Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review 22
The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial 22
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 22
Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: A double-blind, placebo-controlled, randomized study in cancer patients 21
Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 21
Retrievable vena cava filters: a clinical review 21
EXTENDED PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS UNDERGOING MAJOR ORTHOPAEDIC SURGERY IN ITALY: A PHARMACOECONOMIC STUDY 21
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely III Medical Patients: An APEX Trial Substudy 21
A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum) 20
Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban 20
SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature 20
Epidemiology and risk factors of venous thromboembolism 20
Interventional Approaches in VTE Treatment (Vena Cava Filters, Catheter-Guided Thrombolysis, Thrombosuction) 20
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 19
Residual Thrombosis on Ultrasonography to Guide the Duration of Anticoagulation in Patients With Deep Venous Thrombosis 19
Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism 19
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists A meta-analysis 18
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis 18
The Changing Landscape for Stroke Prevention in AF Findings From the GLORIA-AF Registry Phase 2 18
Prophylaxis of venous thromboembolism in bariatric surgery: A prospective randomized study comparing two doses of parnaparin 18
Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study 18
Effectiveness of recombinant factor VIIa in haemorragic cancer-related disseminated intravascular coagulation: a case report 17
Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage 17
Retrievable vena cava filters: Key considerations 17
Venous thromboembolism in patients undergoing shoulder surgery: findings from the Recos registry 16
Successful Protein C Concentrate Administration during Initiation of Oral Anticoagulation in Adult Patients with Severe Congenital Protein C Deficiency: Report of Two Cases 16
Interventional treatment of venous thromboembolism: A review 16
Management of primary care patients with suspected deep vein thrombosis use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation 16
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum) 16
Higher mortality in patients hospitalized for acute aortic rupture or dissection during weekends 16
The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants 16
Prognostic relevance of asymptomatic venous thromboembolism in patients with cancer 16
Venous thromboembolism in patients undergoing shoulder surgery: Findings from the RECOS Registry 16
Higher mortality rate in patients hospitalised for acute pulmonary embolism during weekends 16
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 16
Practical Management of Rivaroxaban for the Treatment of Venous Thromboembolism 15
Extended oral anticoagulant therapy after a first episode of pulmonary embolism 15
Primary prophylaxis of VTE in cancer outpatients 15
The Optimal Duration of Anticoagulant Therapy In patients with Cancer-Related Deep Vein Thrombosis: The Advantage of Using Residual Vein Thrombosis (the Cancer-DACUS Study) 15
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment 15
The practical management of NAO 15
Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry 15
I Study EINSTEIN CHOICE 15
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury A prospective cohort study 14
HIGH PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS HOSPITALIZED FOR SYNCOPE 14
Long term clinical outcomes of cancer associated venous thromboembolism: findings from the MASTER registry 14
Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia 14
Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update 13
Low Molecular Weight Heparins and Glomerular Filtration Rate: A Report to be Considered 13
Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 13
Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope 13
Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study 13
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism 13
Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes 13
Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis 13
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency VKA anticoagulation reversal 13
Treatment of venous thromboembolism with tinzaparin in oncological patients 13
Real-Life Management of Venous Thromboembolism With Rivaroxaban: Results From EXperience VTE, an Italian Epidemiological Survey 13
Risk and prophylaxis of catheter-related venous thromboembolism after cardiac surgery: where is the evidence? 13
Venous thromboembolism prophylaxis in medical patients: Future perspectives 13
Venous Thromboembolism in Patients Undergoing Shoulder Arthroscopy: Findings From the RECOS Registry 13
Management Strategies for Vitamin K Antagonists Reversal in Patients With Major Bleeding: A Survey of Italian Emergency Departments 13
DIRECT ORAL ANTICOAGULANTS: NEW PERSPECTIVES ON REVERSAL AGENTS 13
The MASTER registry on venous thromboembolism: Description of the study cohort 12
Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review 12
Outcome of patients with suspected lower limb symptomatic deep vein thrombosis and a normal ultrasound-based initial diagnostic workup: a prospective study 12
Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study 12
Factors associated with the timing of diagnosis of venous thromboembolism: Results from the MASTER registry 12
Seasonal and Weekly Patterns of Occurrence of Acute Cardiovascular Diseases: Does a Gender Difference Exist? 12
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery 12
Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery 12
Risperidone and pulmonary embolism: a harmful association? Case series and review of the literature 11
Evidence and Clinical Judgment: Vena cava filters 11
Totale 1.872
Categoria #
all - tutte 6.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20262.058 0 0 0 238 322 242 296 100 634 226 0 0
Totale 2.058